Aurora Investment Counsel cut its holdings in shares of IMAX Corporation (NYSE:IMAX – Free Report) by 35.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 44,347 shares of the company’s stock after selling 24,680 shares during the period. Aurora Investment Counsel owned approximately 0.08% of IMAX worth $1,686,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Hedges Asset Management LLC acquired a new stake in IMAX in the fourth quarter worth about $2,088,000. Pier Capital LLC increased its stake in IMAX by 85.0% during the 4th quarter. Pier Capital LLC now owns 244,589 shares of the company’s stock valued at $9,040,000 after buying an additional 112,397 shares during the period. Chase Investment Counsel Corp acquired a new position in IMAX during the 4th quarter valued at about $3,070,000. Westfield Capital Management Co. LP raised its position in shares of IMAX by 44.6% during the 4th quarter. Westfield Capital Management Co. LP now owns 2,346,486 shares of the company’s stock worth $86,726,000 after buying an additional 723,861 shares in the last quarter. Finally, Harbor Capital Advisors Inc. raised its position in shares of IMAX by 50.6% during the 4th quarter. Harbor Capital Advisors Inc. now owns 41,264 shares of the company’s stock worth $1,525,000 after buying an additional 13,872 shares in the last quarter. 93.51% of the stock is owned by institutional investors.
IMAX News Roundup
Here are the key news stories impacting IMAX this week:
- Positive Sentiment: Wedbush reiterated an Outperform rating and $46 price target on IMAX, saying the company is positioned for a stronger second half of 2026 even though Q2 growth is expected to be modest. IMAX seen poised for stronger second half despite expected modest Q2
- Positive Sentiment: Media coverage around The Odyssey highlights strong demand for IMAX 70mm and premium screenings, with fans paying premiums and seeking out limited-format showings. That kind of buzz can support IMAX’s brand and box-office-driven revenue outlook.
- Neutral Sentiment: IMAX said expanding 70mm projector capacity is “not practical,” suggesting demand is real but supply remains limited. This supports the premium value of the format, but it also caps near-term upside from the film’s release.
- Neutral Sentiment: Several articles ahead of earnings emphasize that IMAX is expected to report modest Q2 results and that analysts are watching whether growth accelerates later in the year. Imax (IMAX) Earnings Expected to Grow: What to Know Ahead of Next Week’s Release
- Negative Sentiment: Wells Fargo downgraded IMAX from Overweight to Equal Weight, even while setting a $41 price target. The downgrade could weigh on sentiment by signaling less upside near term. IMAX downgraded by Wells Fargo & Company
Insiders Place Their Bets
Wall Street Analysts Forecast Growth
A number of research firms recently commented on IMAX. Rosenblatt Securities reiterated a “buy” rating and set a $47.00 price objective on shares of IMAX in a research note on Monday, April 20th. Weiss Ratings upgraded IMAX from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday. Wall Street Zen lowered IMAX from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Barrington Research increased their price target on IMAX from $42.00 to $46.00 and gave the company an “outperform” rating in a research note on Friday, May 1st. Finally, Wells Fargo & Company reiterated an “equal weight” rating and set a $41.00 price target (down from $47.00) on shares of IMAX in a research report on Thursday. Nine analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $47.30.
Get Our Latest Stock Report on IMAX
IMAX Price Performance
IMAX stock opened at $39.09 on Friday. The firm’s 50 day simple moving average is $39.32 and its 200-day simple moving average is $37.90. The company has a market cap of $2.15 billion, a P/E ratio of 60.14, a price-to-earnings-growth ratio of 1.44 and a beta of 0.37. IMAX Corporation has a fifty-two week low of $24.20 and a fifty-two week high of $45.52.
IMAX (NYSE:IMAX – Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.15 by $0.02. IMAX had a net margin of 9.08% and a return on equity of 13.61%. The business had revenue of $81.38 million during the quarter, compared to the consensus estimate of $79.82 million. During the same quarter in the prior year, the firm earned $0.13 EPS. The firm’s quarterly revenue was down 6.1% on a year-over-year basis. On average, analysts expect that IMAX Corporation will post 1.3 EPS for the current fiscal year.
IMAX Profile
IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.
Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.
Further Reading
- Five stocks we like better than IMAX
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.
